Editor’s note: This is a developing news story. Please check back soon for updates.
EssilorLuxottica added to its medical technology portfolio with the acquisition of Ikerian AG, a Swiss health tech company doing business under the name RetinAI, according to a press release.
The company’s flagship product is RetinAI Discovery, a clinical software platform for managing patient data and imagery, with AI-based disease monitoring capabilities. It also makes Discovery Unity, another data management platform geared toward clinical studies and pharmaceutical research and development.
“RetinAI